Amphastar Pharmaceuticals
AMPH
#4373
Rank
NZ$3.39 B
Marketcap
$70.62
Share price
-3.31%
Change (1 day)
-24.50%
Change (1 year)

Earnings for Amphastar Pharmaceuticals (AMPH)

Earnings in 2024 (TTM): NZ$0.35 Billion

According to Amphastar Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.72 Billion. In 2023 the company made an earning of NZ$0.34 Billion, an increase over its 2022 earnings that were of NZ$0.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Amphastar Pharmaceuticals from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.35 B4.07%
2023 NZ$0.34 B68.4%
2022 NZ$0.20 B38.65%
2021 NZ$0.14 B1596.75%
2020 NZ$8.66 M-91.7%
2019 NZ$0.10 B-723.23%
2018 -NZ$16.75 Million-516.29%
2017 NZ$4.02 M-85.44%
2016 NZ$27.61 M-270.31%
2015 -NZ$16.22 Million-46.53%
2014 -NZ$30.33 Million-196.44%
2013 NZ$31.44 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$0.25 Billion-163.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$61.1 Million-116.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$25.99 Million-106.81%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.14 Billion-136.70%๐Ÿ‡บ๐Ÿ‡ธ USA